Your Location：
Home >
Browse articles >
Anti-inflammatory Mechanism of Modified Erchentang on Chronic Obstructive Pulmonary Disease Through Jagged1/Notch1/Hes1 Signaling Pathway
Anti-inflammatory Mechanism of Modified Erchentang on Chronic Obstructive Pulmonary Disease Through Jagged1/Notch1/Hes1 Signaling Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 9, Pages: 109-118(2023)
DOI： 10.13422/j.cnki.syfjx.20230109
Scan QR Code
Full Text(HTML)
Figs( 5 ) Tabs( 4 )
References
Publication Info
Metrics
198
Views
113
Downloads
4
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Modified Erchentang Alleviates Inflammation in Chronic Obstructive Pulmonary Disease via Midkine/Notch2/Hey1 Signaling Pathway in Rats
Effect of Modified Erchentang on Bronchioles of Rats with Chronic Obstructive Pulmonary Disease by HMGB1/RAGE/NF-κB Signaling Pathway
Erchentang Alleivates Depression in Obese Mice by Regulating PPAR Signaling Pathway
Network Pharmacology and Animal Experiments Reveal Mechanism of Daturae Flos in Ameliorating Chronic Obstructive Pulmonary Disease
Erchentang Ameliorates SiO2-induced Lung Injury by Regulating Oxidative Stress and Metabolic Disorders via Nrf2/HO-1 Signaling Pathway
Related Author
HU Wenhao
LI Yaoyang
LIU Gaoyang
CHEN Zhuang
WANG Qi
YU Qiao
HU Shiwei
ZHANG Jinrong
Related Institution
Henan Provincial Second People's Hospital
Hubei Shizhen Laboratory
School of Basic Medical Sciences， Hubei University of Chinese Medicine
Central Theater Command General Hospital of the People's Liberation Army
The Fourth School of Clinical Medicine，Guangzhou University of Chinese Medicine
Chat
